S&P 500
7,376.86
+23.13
+0.31%
Dow
51,285.73
-237.37
-0.46%
Nasdaq
24,579.42
+264.42
+1.09%
NYSE Composite
23,950.37
-5.63
-0.02%
Russell 2000
2,754.11
+24.22
+0.89%
VIX
25.64
-2.54
-9.01%
CGON · CG Oncology, Inc. Common stock
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
CG Oncology, Inc. (CGON)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$75.94
+11.19
(+17.28%)
● At close: November 6 at 4:00:00 PM EDT
DAY'S RANGE
$75.94
$67.31
$79.64
52-WEEK RANGE
$75.94
$35.80
$80.97
What's happening
- CGON is up 17.28% today, trading at $75.94. — Live quote
- Volume today (186,765) is well below its 3-month average of 927,140. (Finnhub fundamentals)
- Reports earnings on 2026-11-12, 3 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.64 actual vs. $-0.86 estimated (+25.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 14
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-11-01 (21 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CGON
+83.02%
vs S&P 500
+75.19%
1-YEAR RETURN
CGON
+91.46%
vs S&P 500
+81.76%
6-MONTH RETURN
CGON
+13.12%
3-MONTH RETURN
CGON
+1.19%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-11-06 (Q3 2026)
$-0.64
Est. $-0.86
BEAT +25.4%
2026-07-26 (Q2 2026)
$-0.90
Est. $-0.68
MISS -32.8%
2026-04-26 (Q1 2026)
$-0.71
Est. $-0.58
MISS -23.0%
2026-01-26 (Q4 2025)
$-0.53
Est. $-0.63
BEAT +15.4%
Valuation Measures & Ratios
Enterprise Value4$6.72B
Forward P/E5—
PEG Ratio6-0.38
Price / Sales (TTM1)1081.53
Price / Book76.09
EV4 / Revenue1078.86
EV4 / EBITDA—
Profit Margin-3602.68%
Operating Margin-4056.18%
Return on Equity (ROE8)-25.20%
Return on Assets (ROA9)-23.98%
Avg Volume (3M)927,140
Quarterly history (5 periods)
| Measure | Sep '26 | Jun '26 | Mar '26 | Sep '25 | Jun '25 |
|---|---|---|---|---|---|
| Market cap | $6.30B | $6.24B | $5.75B | $3.10B | $1.99B |
| P/E | -26.27 | -27.79 | -31.95 | -22.11 | -17.31 |
| Price/Book | 6.36 | 6.06 | 5.26 | 4.51 | 2.97 |
| EV/EBITDA | -23.79 | -24.84 | -27.62 | — | — |
| ROE | -24.21% | -21.81% | -16.48% | -20.37% | -17.18% |
| ROA | -22.93% | -20.68% | -15.85% | -19.19% | -16.42% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short8,873,120
Change from Prior Settlement-15.02%
% of Float—
Days to Cover (Short Ratio)9.65
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-10-15. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +91.5%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -3602.7%. Finnhub fundamentals ↗
- Latest SEC filing is Form 10-Q, filed 2026-11-06; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CGON
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Sep '26 | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$63.2M | -$86.4M | -$66.4M | -$51.1M | -$48.7M | -$42.2M | -$28.3M | -$25.9M |
| Net income | -$56.9M | -$79.1M | -$60.2M | -$43.8M | -$41.4M | -$34.5M | -$20.4M | -$18.9M |
| EPS (diluted) | $-0.64 | $-0.90 | $-0.71 | $-0.57 | $-0.54 | $-0.45 | $-0.30 | $-0.28 |
| EPS (basic) | $-0.64 | $-0.90 | $-0.71 | $-0.57 | $-0.54 | $-0.45 | $-0.30 | $-0.28 |
Balance sheet
| Line item | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jul '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.05B | $1.09B | $1.14B | $791.6M | $729.9M | — | $701.4M | $728.2M |
| Total liabilities | $55.7M | $56.5M | $43.5M | $39.0M | $42.3M | — | $31.1M | $23.4M |
| Stockholders' equity | $991.0M | $1.03B | $1.09B | $752.6M | $687.6M | — | $670.4M | $704.8M |
| Total current assets | $1.01B | $1.05B | $1.10B | $759.5M | $695.8M | — | $673.0M | $701.2M |
| Total current liabilities | $46.4M | $47.2M | $35.2M | $30.8M | $30.5M | — | $30.4M | $22.6M |
| Cash & equivalents | $28.2M | $19.6M | $33.7M | $32.5M | $45.1M | — | $14.6M | $41.5M |
| Marketable securities (current) | $956.2M | $1.01B | $1.04B | $709.7M | $635.1M | — | $646.4M | $647.0M |
| Accounts receivable | $666.0K | $417.0K | $1.3M | $688.0K | $515.0K | — | — | — |
| Inventory | $1.2M | $1.0M | $1.5M | $1.6M | $1.5M | — | — | — |
| Property, plant & equipment | $14.9M | $14.7M | $15.1M | $15.6M | $15.3M | — | $253.0K | $264.0K |
| Goodwill | $10.3M | $10.3M | $10.3M | $10.3M | $12.8M | $10.3M | — | — |
| Intangible assets | $530.0K | $545.0K | $560.0K | $575.0K | $1.7M | — | — | — |
| Other non-current assets | $6.9M | $4.7M | $2.7M | $1.7M | $114.0K | — | $522.0K | $516.0K |
| Accounts payable | $9.8M | $12.7M | $8.2M | $5.7M | $9.2M | — | $7.1M | $6.7M |
| Deferred revenue (current) | $29.0K | — | — | $286.0K | — | — | — | — |
| Long-term debt | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | — | — | — |
| Other non-current liabilities | $855.0K | $1.2M | $1.5M | $1.7M | $3.8M | — | — | — |
| Common stock & paid-in capital | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | — | $8.0K | $8.0K |
| Retained earnings | -$575.1M | -$518.2M | -$439.2M | -$379.0M | -$337.7M | — | -$293.9M | -$252.4M |
Cash flow
| Line item | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$47.7M | -$46.4M | -$56.9M | -$36.2M | -$38.9M | -$28.0M | -$29.3M | -$20.7M |
| Investing cash flow | $46.0M | $30.4M | -$334.8M | -$75.5M | $15.0M | $1.4M | -$186.8M | $10.9M |
| Financing cash flow | $10.3M | $1.9M | $393.0M | $99.1M | $54.4M | -$296.0K | $450.0K | $223.4M |
| Free cash flow | -$48.8M | -$46.9M | -$57.2M | -$36.2M | -$39.0M | -$28.0M | -$29.3M | -$20.9M |
| Capital expenditures | $1.1M | $468.0K | $304.0K | $7.0K | $97.0K | $14.0K | $16.0K | $209.0K |
| Depreciation & amortization | $1.2M | $850.0K | $841.0K | $849.0K | $416.0K | $156.0K | $24.0K | $0 |
| Share-based compensation | $8.5M | $14.3M | $6.5M | $7.2M | $7.3M | $7.0M | $5.2M | $5.0M |
| Deferred income taxes | — | — | — | -$278.0K | — | — | — | — |
| Change in accounts receivable | $249.0K | -$858.0K | $587.0K | $301.0K | $19.0K | — | — | — |
| Change in inventory | $162.0K | -$490.0K | -$72.0K | $64.0K | $380.0K | — | — | — |
| Change in accounts payable | -$3.0M | $4.5M | $2.5M | -$3.5M | $1.2M | $394.0K | $214.0K | $2.4M |
| Purchases of investments | $905.9M | — | — | — | $770.1M | — | — | — |
| Tax withholding on stock comp | $3.0K | $20.0K | $174.0K | — | $0 | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 |
|---|---|---|---|
| Operating income | -$190.8M | -$114.7M | -$55.4M |
| Net income | -$161.0M | -$88.0M | -$48.6M |
| EPS (diluted) | $-2.08 | $-1.41 | $-15.65 |
| EPS (basic) | $-2.08 | $-1.41 | $-15.65 |
Balance sheet
| Line item | Dec '25 | Jul '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| Total assets | $791.6M | — | $754.8M | $199.3M | — |
| Total liabilities | $39.0M | — | $21.4M | $14.5M | — |
| Stockholders' equity | $752.6M | — | $733.4M | -$123.1M | -$77.7M |
| Total current assets | $759.5M | — | $754.2M | $194.1M | — |
| Total current liabilities | $30.8M | — | $21.4M | $14.3M | — |
| Cash & equivalents | $32.5M | — | $257.1M | $8.3M | — |
| Marketable securities (current) | $709.7M | — | $484.9M | $179.4M | — |
| Accounts receivable | $688.0K | — | $0 | — | — |
| Inventory | $1.6M | — | $0 | — | — |
| Property, plant & equipment | $15.6M | — | $272.0K | $69.0K | — |
| Goodwill | $10.3M | $10.3M | $0 | — | — |
| Intangible assets | $575.0K | — | $0 | — | — |
| Other non-current assets | $1.7M | — | $94.0K | $19.0K | — |
| Accounts payable | $5.7M | — | $6.5M | $3.2M | — |
| Long-term debt | $3.0M | — | $0 | — | — |
| Other non-current liabilities | $1.7M | — | $0 | — | — |
| Common stock & paid-in capital | $8.0K | — | $8.0K | — | — |
| Retained earnings | -$379.0M | — | -$218.0M | -$129.9M | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 |
|---|---|---|---|
| Operating cash flow | -$132.3M | -$78.7M | -$45.7M |
| Investing cash flow | -$245.8M | -$300.8M | -$121.2M |
| Financing cash flow | $153.6M | $628.3M | $87.0M |
| Free cash flow | -$132.5M | -$78.9M | — |
| Capital expenditures | $134.0K | $234.0K | — |
| Depreciation & amortization | $1.4M | $32.0K | $17.0K |
| Share-based compensation | $26.7M | $11.4M | $1.5M |
| Deferred income taxes | -$278.0K | — | — |
| Change in accounts receivable | $320.0K | — | — |
| Change in inventory | $444.0K | — | — |
| Change in accounts payable | -$1.6M | $3.3M | $2.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CGON as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-04 to 2026-10-15
Recent transactions
- Insiders have net bought 329,956 shares over the last 182 days, across 1 purchase and 11 sales.
- Most recent: POST LEONARD E (Reporting person) — Option exercise of 1,000 shares on 2026-10-15.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)371,085 sh(1 txns)
Sales (open market)41,129 sh(11 txns)
Net Shares+329,956
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| POST LEONARD E | Reporting person | Option exercise | 2026-10-15 | 1,000 |
| Mulay James | Reporting person | Option exercise | 2026-07-10 | 24,165 |
| Liu Brian Guan-Chyun | Reporting person | Open market purchase | 2026-06-25 | 371,085 |
| Kuan Arthur | Chief Executive Officer | Option exercise | 2026-03-12 | 64,612 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-15 | POST LEONARD E | Reporting person | Option exercise | 1,000 | $0.60 |
| 2026-10-15 | POST LEONARD E | Reporting person | Open market sale | 500 | $61.65 |
| 2026-10-15 | POST LEONARD E | Reporting person | Open market sale | 500 | $62.48 |
| 2026-09-15 | POST LEONARD E | Reporting person | Option exercise | 1,000 | $0.60 |
| 2026-09-15 | POST LEONARD E | Reporting person | Open market sale | 1,000 | $72.98 |
| 2026-08-14 | POST LEONARD E | Reporting person | Option exercise | 1,000 | $0.60 |
| 2026-08-14 | POST LEONARD E | Reporting person | Open market sale | 1,000 | $74.54 |
| 2026-07-15 | POST LEONARD E | Reporting person | Option exercise | 1,000 | $0.60 |
| 2026-07-15 | POST LEONARD E | Reporting person | Open market sale | 1,000 | $71.17 |
| 2026-07-10 | Mulay James | Reporting person | Option exercise | 24,165 | $26.63 |
| 2026-07-10 | Mulay James | Reporting person | Open market sale | 24,165 | $75.16 |
| 2026-06-25 | Liu Brian Guan-Chyun | Reporting person | Open market purchase | 371,085 | $66.87 |
| 2026-06-24 | POST LEONARD E | Reporting person | Option exercise | 5,000 | $0.60 |
| 2026-06-24 | POST LEONARD E | Reporting person | Open market sale | 5,000 | $70.00 |
| 2026-06-22 | POST LEONARD E | Reporting person | Option exercise | 5,000 | $0.60 |
| 2026-06-22 | POST LEONARD E | Reporting person | Open market sale | 5,000 | $65.00 |
| 2026-06-15 | Mulay James | Reporting person | Option exercise | 654 | $3.72 |
| 2026-06-15 | Mulay James | Reporting person | Open market sale | 654 | $60.12 |
| 2026-06-15 | Mulay James | Reporting person | Option exercise | 1,310 | $12.59 |
| 2026-06-15 | Mulay James | Reporting person | Open market sale | 1,310 | $60.12 |
| 2026-06-04 | POST LEONARD E | Reporting person | Option exercise | 1,000 | $0.60 |
| 2026-06-04 | POST LEONARD E | Reporting person | Open market sale | 1,000 | $54.50 |
| 2026-04-17 | Mulay James | Reporting person | Option exercise | 15,600 | $36.63 |
| 2026-04-17 | Mulay James | Reporting person | Open market sale | 15,600 | $73.01 |
| 2026-03-16 | Mulay James | Reporting person | Option exercise | 654 | $3.72 |
| 2026-03-16 | Mulay James | Reporting person | Open market sale | 654 | $63.50 |
| 2026-03-16 | Mulay James | Reporting person | Option exercise | 1,310 | $12.59 |
| 2026-03-16 | Mulay James | Reporting person | Open market sale | 1,310 | $63.50 |
| 2026-03-12 | Kuan Arthur | Chief Executive Officer | Option exercise | 64,612 | $1.72 |
| 2026-03-12 | Kuan Arthur | Chief Executive Officer | Tax withholding | 1,847 | $60.15 |
| 2026-03-04 | Kuan Arthur | Chief Executive Officer | Option exercise | 102,871 | $1.72 |
| 2026-03-04 | Kuan Arthur | Chief Executive Officer | Tax withholding | 2,871 | $61.61 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-11-09 02:45 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-11-06 | 10-Q | 2026-09-30 | View on SEC.gov → |
| 2026-11-06 | 8-K | 2026-11-06 | View on SEC.gov → |
| 2026-10-19 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-19 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-09-17 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-15 | View on SEC.gov → |
| 2026-07-14 | 4 | 2026-07-10 | View on SEC.gov → |
| 2026-06-29 | 4 | 2026-06-25 | View on SEC.gov → |
| 2026-06-25 | 4 | 2026-06-24 | View on SEC.gov → |
Recent news
Headlines about CGON (CG Oncology, Inc. Common stock). Links open the publisher — we don’t host full articles.
-
CGON SWOT Analysis: Financial Challenges and Growth Potential Re
GuruFocus · 2026-11-07 -
Technical Reactions to CGON Trends in Macro Strategies
Stock Traders Daily · 2026-11-07 -
CG Oncology, Inc. (CGON) Reports Q3 Loss, Beats Revenue Estimates
Yahoo · 2026-11-06 -
With $984.5M in cash and securities, CG Oncology (CGON) posts a wider Q3 loss.
Stock Titan · 2026-11-06 -
CG Oncology GAAP EPS of -$0.64 beats by $0.20, revenue of $1.6M beats by $1.07M
Seeking Alpha · 2026-11-06 -
CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates
Yahoo · 2026-11-06 -
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 2026-11-06 -
CGON Nov 2026 80.000 put (CGON261120P00080000) stock price, news, quote and history
Yahoo Finance UK · 2026-11-06
No headlines in this category right now — try “All”.